Inventor
Jed WILTZIUS
Inventor
US
Overview
Patents· 7 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C07Kprimary
C07KPeptides23%
A61KPreparations for medical, dental or toiletry purposes20%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations20%
C12NMicroorganisms or enzymes13%
G01NInvestigating or analysing materials by determining their chemical or physical properties13%
C12PFermentation or enzyme-using processes to synthesise a desired chemical compound or composition or to separate optical isomers from a racemic mixture3%
C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms3%
Y02ATechnologies for adaptation to climate change3%
PatentTitleYear
12,583,923Chimeric antigen and T cell receptors and methods of use202612,202,909Antigen binding molecules specific for an anti-CD19 scFV202511,820,823T cell receptor antigen binding molecules and methods of use thereof202311,793,834Chimeric antigen and T cell receptors and methods of use202311,608,517Antigen binding molecules and methods of use thereof202311,505,613BCMA binding molecules and methods of use thereof202211,384,155Antigen binding molecules specific for an anti-CD19 scFv2022Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2022–2026Patents assigned to KITE PHARMA INC (7)· patent assignee history
2022–2026Based in US· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| KITE PHARMA INC | 7 | 2022–2026 |
Locations
| Location | Patents | Span |
|---|---|---|
| US | 7 | 2022–2026 |